The Cancer Genome Atlas is a project to catalogue the genomic alterations responsible for cancer using genome sequencing and bioinformatics. From Wikipedia
Researchers can now pursue preclinical lncRNA-based therapies after confirming LINC01235’s role in driving NFIB expression through the NOTCH pathway in aggressive triple-negative tumors.
